prospective, controlled cohort study is the first to compare outcomes in women exposed to
an SSRI during the last trimester of pregnancy with matched controls. "Of the 55
neonates exposed to paroxetine in late gestation, 12 had complications necessitating
intensive treatment and prolonged hospitalisation. The most prevalent clinical picture was
respiratory distress (n=9), followed by hypoglycaemia (n=2) and jaundice (n=1). The
symptoms disappeared within 1 to 2 weeks. In the comparison group, only 3 infants
experienced complications (p=.03)."